
Auteur D. M. WOOD
|
Documents disponibles écrits par cet auteur (44)

J. GLANVILLE ; P. I. DARGAN ; D. M. WOOD | 2015
Dans Human Psychopharmacology: Clinical and Experimental (Vol.30, n°3, May 2015) Article : PériodiqueObjective: 4-Methyl-5-(4-methylphenyl)-4,5-dihydrooxazol-2-amine (4,4'-dimethylaminorex (4,4'-DMAR)) is a derivative of the controlled substances aminorex and 4-methylaminorex marketed as a potential novel psychoactive substance. This paper brin[...]
FRANÇAIS : On cherche à déterminer le taux d'acquisition et de perte de tolérance aux stimuli discriminatoires de la cocaïne et la possibilité d'une tolérance croisée conférée par la cocaïne pour la methamphétamine et la phénylalamine. Dans ce [...]
A. M. DINES ; D. M. WOOD ; C. YATES ; F. HEYERDAHL ; K. E. HOVDA ; I. GIRAUDON ; R. SEDEFOV ; P. I. DARGAN ; Euro-DEN Research Group | 2015
Dans Clinical Toxicology (Vol.53, n°9, November 2015) Article : PériodiqueCONTEXT: Despite the potential for recreational drugs and new psychoactive substances (NPSs) to cause significant morbidity and mortality, there is limited collection of systematic data on acute drug/NPS toxicity in Europe. OBJECTIVE: To report[...]
E. LIAKONI ; C. YATES ; A. M. DINES ; P. I. DARGAN ; F. HEYERDAHL ; K. E. HOVDA ; D. M. WOOD ; F. EYER ; M. E. LIECHTI ; Euro-DEN Plus Research Group | 2018
Dans Medicine (Vol.97, n°5, February 2018) Article : PériodiqueThe aim of the study was to compare self-reported and analytically confirmed substance use in cases of acute recreational drug toxicity. We performed a retrospective analysis of emergency department presentations of acute recreational drug toxi[...]
J. R. H. ARCHER ; S. HUDSON ; O. JACKSON ; T. YAMAMOTO ; C. LOVETT ; H. M. LEE ; S. RAO ; L. HUNTER ; P. I. DARGAN ; D. M. WOOD | 2015
Dans QJM (Vol.108, n°12, December 2015) Article : PériodiqueBackground: Analysis of anonymous pooled urine samples from street urinals has been used to demonstrate time-trends in the detection of classical recreational drugs and novel psychoactive substances (NPS). Aim: This study aimed to expand this t[...]
J. R. H. ARCHER ; P. I. DARGAN ; S. HUDSON ; D. M. WOOD | 2013
Dans QJM (Vol.106, n°2, February 2013) Article : PériodiqueAim: Analysis of urine samples collected across a city centre, for the detection of novel psychoactive substances (NPS). Design: Cross-sectional study of anonymized urine samples used for the analysis of classical recreational drugs, NPS and me[...]
J. R. H. ARCHER ; P. O. BEAUMONT ; D. MAY ; P. I. DARGAN ; D. M. WOOD | 2012
Dans Journal of Substance Use (Vol.17, n°4, August 2012) Article : PériodiqueBackground: The published ambulance referral criteria (ARC) for assessing individuals with acute recreational drug toxicity in the prehospital setting consist of nine domains. The ARC recommend that an ambulance is called to transfer those with [...]
D. M. WOOD ; P. I. DARGAN ; J. BUTTON ; D. W. HOLT ; H. OVASKA ; J. RAMSEY ; A. L. JONES | 2007
Dans Lancet (The) (Vol.369, n°9571, Apr 28, 2007) Article : Périodique
F. HEYERDAHL ; K. E. HOVDA ; I. GIRAUDON ; C. B. YATES ; A. M. DINES ; R. SEDEFOV ; D. M. WOOD ; P. I. DARGAN | 2014
Dans Clinical Toxicology (Vol.52, n°10, December 2014) Article : PériodiqueBACKGROUND: The number of new (novel) psychoactive substances (NPS) available in the illegal market is increasing; however, current monitoring of the drug situation in Europe focuses mainly on classical drugs of abuse, with limited emphasis on c[...]
K. MOORE ; P. I. DARGAN ; D. M. WOOD ; F. MEASHAM | 2013
Dans European Addiction Research (Vol.19, n°5, September 2013) Article : PériodiqueBackground/Aims: To assess whether novel psychoactive substances (NPS) displace established club drugs, supplement them or act as drugs of initiation via a study of the relationship between mephedrone, ecstasy pills, cocaine and MDMA powder amon[...]
O. MIRO ; P. I. DARGAN ; D. M. WOOD ; A. M. DINES ; C. YATES ; F. HEYERDAHL ; K. E. HOVDA ; I. GIRAUDON ; Euro-DEN Plus Research Group ; M. GALICIA | 2019
Dans Clinical Toxicology (Vol.57, n°8, August 2019) Article : PériodiqueObjective: To analyse the epidemiology, clinical picture and emergency department (ED) management of a large series of patients who presented to European EDs after cocaine consumption, comparing data from powder (C-1 group) and crack (C-2 group)[...]
J. H. HO ; G. P. BAILEY ; J. R. H. ARCHER ; P. I. DARGAN ; D. M. WOOD | 2015
Dans European Journal of Clinical Pharmacology (Vol.71, n°10, October 2015) Article : PériodiquePurpose: Ethylphenidate is a novel psychoactive substance that is an analogue of methylphenidate. This paper describes its availability, patterns of use, and acute effects. Methods: Searches of the scientific and grey literature (publicly acces[...]
J. R. H. ARCHER ; F. MENDES ; S. HUDSON ; K. LAYNE ; P. I. DARGAN ; D. M. WOOD | 2020
Dans British Journal of Clinical Pharmacology (Vol.86, n°3, March 2020) Article : PériodiqueAims: To evaluate the long-term trends of new psychoactive substance (NPS) detection in pooled urine samples collected across a city centre. Methods: Pooled urine samples from portable stand-alone urinals were collected on a monthly basis over[...]
H. M. D. LEE ; K. BONNICI ; J. R. H. ARCHER ; P. I. DARGAN ; D. M. WOOD | 2016
Dans Journal of Substance Use (Vol.21, n°2, April 2016) Article : PériodiqueBackground: Acute recreational drug toxicity is a common cause of emergency department (ED) presentations. There is limited published information on the perception, knowledge and experiences of these patients with regards to seeking medical care[...]
C. LEAPER ; A. M. DINES ; P. I. DARGAN ; C. YATES ; K. E. HOVDA ; F. HEYERDAHL ; I. GIRAUDON ; D. M. WOOD ; Euro-DEN Plus Research Group | 2021
Dans European Journal of Emergency Medicine (Vol.28, n°2, April 2021) Article : PériodiqueOver the last few years, there have been increasing reports of the potential for dependence and misuse of gabapentinoids such as pregabalin. Recent data from the UK have demonstrated an increase in 'gabapentinoid' deaths from 1 death in 2009 to [...]